FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yoshiaki Taniyama

Research Profile

Chemicals & Drugs

Procedures

Genetic Therapy

Physiology

Anatomy

Living Beings

Devices

Disorders

Co-author Network

Publications

TOP 3
Hiroshi Kusunoki; Hiromi Rakugi; Yoshiaki Taniyama; Ryuichi Morishita
Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension.
Kazutaka Shimizu; Yoshiaki Taniyama; Hiromi Rakugi; Fumihiro Sanada; Junya Azuma; Kazuma Iekushi; Masaaki Iwabayashi; Ryuichi Morishita
Hepatocyte growth factor inhibits lipopolysaccharide-induced oxidative stress via epithelial growth factor receptor degradation.
Masaaki Iwabayashi; Junya Azuma; Amarnath Chatterjee; Kazuma Iekushi; Keita Okayama; Hiromi Rakugi; Fumihiro Sanada; Yoshiaki Taniyama; Ryuichi Morishita
Inhibition of Lp(a)-induced functional impairment of endothelial cells and endothelial progenitor cells by hepatocyte growth factor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yoshiaki Taniyama (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Hiroshi Kusunoki; Hiromi Rakugi; Yoshiaki Taniyama; Ryuichi Morishita
Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension.
Journal of the American Heart Association 2013;2(2):e000103.
2012: Kazutaka Shimizu; Yoshiaki Taniyama; Hiromi Rakugi; Fumihiro Sanada; Junya Azuma; Kazuma Iekushi; Masaaki Iwabayashi; Ryuichi Morishita
Hepatocyte growth factor inhibits lipopolysaccharide-induced oxidative stress via epithelial growth factor receptor degradation.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(11):2687-93.
2012: Masaaki Iwabayashi; Junya Azuma; Amarnath Chatterjee; Kazuma Iekushi; Keita Okayama; Hiromi Rakugi; Fumihiro Sanada; Yoshiaki Taniyama; Ryuichi Morishita
Inhibition of Lp(a)-induced functional impairment of endothelial cells and endothelial progenitor cells by hepatocyte growth factor.
Biochemical and biophysical research communications 2012;423(1):79-84.
2012: Keita Okayama; Hiromi Rakugi; Fumihiro Sanada; Yoshiaki Taniyama; Junya Azuma; Norio Dosaka; Kazuma Iekushi; Masaaki Iwabayashi; Hiroshi Kusunoki; Ryuichi Morishita
Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial-mesenchymal transition.
Hypertension 2012;59(5):958-65.
2012: Munehisa Shimamura; Yoshiaki Taniyama; Kouji Wakayama; Hironori Nakagami; Naoyuki Sato; Mohammad Allahtavakoli; Naruto Katsuragi; Nobutaka Koibuchi; Mariko Kyutoku; Ryuichi Morishita
Role of central nervous system periostin in cerebral ischemia.
Stroke; a journal of cerebral circulation 2012;43(4):1108-14.
2012: Hiroshi Kusunoki; Junya Azuma; Kazuma Iekushi; Masaaki Iwabayashi; Keita Okayama; Rei Otsu; Hiromi Rakugi; Fumihiro Sanada; Yoshiaki Taniyama; Ryuichi Morishita
Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.
Hypertension 2012;59(2):308-16.
2012: Masaaki Iwabayashi; Hiroshi Kusunoki; Junya Azuma; Amarnath Chatterjee; Kazuma Iekushi; Keita Okayama; Hiromi Rakugi; Fumihiro Sanada; Yoshiaki Taniyama; Ryuichi Morishita
Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice.
Atherosclerosis 2012;220(2):337-42.
2012: Yoshiaki Taniyama; Hiromi Rakugi; Junya Azuma; Kazuma Iekushi; Yasuo Kunugiza; Ryuichi Morishita
Therapeutic option of plasmid-DNA based gene transfer.
Current topics in medicinal chemistry 2012;12(15):1630-7.
2012: Munehisa Shimamura; Yoshiaki Taniyama; Hironori Nakagami; Naoyuki Sato; Ryuichi Morishita
Development of nucleic acid drugs for neurological disorders.
Current topics in medicinal chemistry 2012;12(15):1621-9.
2011: Yoshiaki Taniyama; Junya Azuma; Masaaki Iwabayashi; Ryuichi Morishita; Hiromi Rakugi
[Therapeutic angiogenesis for coronary artery].
Nihon rinsho. Japanese journal of clinical medicine 2011;69 Suppl 7():74-9.
2011: Kazuma Iekushi; Masaaki Iwabayashi; Nobutaka Koibuchi; Hiroshi Kusunoki; Keita Okayama; Hiromi Rakugi; Fumihiro Sanada; Yoshiaki Taniyama; Junya Azuma; Ryuichi Morishita
Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathway.
Hypertension 2011;58(2):190-6.
2011: Mariko Kyutoku; Yoshiaki Taniyama; Naruto Katsuragi; Hideo Shimizu; Yasuo Kunugiza; Kazuma Iekushi; Nobutaka Koibuchi; Fumihiro Sanada; Yoshihiro Oshita; Ryuichi Morishita
Role of periostin in cancer progression and metastasis: inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model.
International journal of molecular medicine 2011;28(2):181-6.
2011: Wataru Shioyama; Yoshikazu Nakaoka; Kaori Higuchi; Takashi Minami; Yoshiaki Taniyama; Keigo Nishida; Hiroyasu Kidoya; Takashi Sonobe; Hisamichi Naito; Yoh Arita; Takahiro Hashimoto; Tadashi Kuroda; Yasushi Fujio; Mikiyasu Shirai; Nobuyuki Takakura; Ryuichi Morishita; Keiko Yamauchi-Takihara; Tatsuhiko Kodama; Toshio Hirano; Naoki Mochizuki; Issei Komuro
Docking protein Gab1 is an essential component of postnatal angiogenesis after ischemia via HGF/c-met signaling.
Circulation research 2011;108(6):664-75.
2011: Ryuichi Morishita; Hirofumi Makino; Motokuni Aoki; Naotaka Hashiya; Keita Yamasaki; Junya Azuma; Yoshiaki Taniyama; Yoshiki Sawa; Yasufumi Kaneda; Toshio Ogihara
Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia.
Arteriosclerosis, thrombosis, and vascular biology 2011;31(3):713-20.
2010: Kazuma Iekushi; Yoshiaki Taniyama; Junya Azuma; Fumihiro Sanada; Hiroshi Kusunoki; Toyohiko Yokoi; Nobutaka Koibuchi; Keita Okayama; Hiromi Rakugi; Ryuichi Morishita
Hepatocyte growth factor attenuates renal fibrosis through TGF-β1 suppression by apoptosis of myofibroblasts.
Journal of hypertension 2010;28(12):2454-61.
2010: Yoshiaki Taniyama; Fumihiro Sanada; Keita Okayama; Hiroshi Kusunoki; Ryuichi Morishita
[Gene therapy for vascular disease].
Nihon rinsho. Japanese journal of clinical medicine 2010;68 Suppl 8():641-5.
2010: Futoshi Nakagami; Hironori Nakagami; Mariana Kiomy Osako; Masaaki Iwabayashi; Yoshiaki Taniyama; Takefumi Doi; Hideo Shimizu; Munehisa Shimamura; Hiromi Rakugi; Ryuichi Morishita
Estrogen attenuates vascular remodeling in Lp(a) transgenic mice.
Atherosclerosis 2010;211(1):41-7.
2010: Yoshiaki Taniyama; Fumihiro Sanada; Ryuichi Morishita
[Therapeutic angiogenesis for diabetes mellitus related ischemic disease].
Nihon rinsho. Japanese journal of clinical medicine 2010;68(5):949-52.
2010: Yoshiaki Taniyama; Ryuichi Morishita
Does therapeutic angiogenesis overcome CKD?
Hypertension research : official journal of the Japanese Society of Hypertension 2010;33(2):114-5.
2009: Fumihiro Sanada; Yoshiaki Taniyama; Kazuma Iekushi; Junya Azuma; Keita Okayama; Hiroshi Kusunoki; Nobutaka Koibuchi; Takefumi Doi; Yoshifusa Aizawa; Ryuichi Morishita
Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells.
Circulation research 2009;105(7):667-75, 13 p following 675.
2008: Kaori Nagao; Yoshiaki Taniyama; Thomas Kietzmann; Takefumi Doi; Issei Komuro; Ryuichi Morishita
HIF-1alpha signaling upstream of NKX2.5 is required for cardiac development in Xenopus.
The Journal of biological chemistry 2008;283(17):11841-9.
2007: Kaori Nagao; Yoshiaki Taniyama; Nobutaka Koibuchi; Ryuichi Morishita
Constitutive over-expression of VEGF results in reduced expression of Hand-1 during cardiac development in Xenopus.
Biochemical and biophysical research communications 2007;359(3):431-7.
2007: Kazuma Iekushi; Yoshiaki Taniyama; Junya Azuma; Naruto Katsuragi; Norio Dosaka; Fumihiro Sanada; Nobutaka Koibuchi; Kaori Nagao; Toshio Ogihara; Ryuichi Morishita
Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin.
Hypertension 2007;49(6):1409-14.
2006: Junya Azuma; Yoshiaki Taniyama; Y Takeya; Kazuma Iekushi; Motokuni Aoki; N Dosaka; Kunihiro Matsumoto; Tadashi Nakamura; Toshio Ogihara; Ryuichi Morishita
Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy.
Gene therapy 2006;13(16):1206-13.
2006: Yasuo Kunugiza; Naruya Tomita; Yoshiaki Taniyama; Tetsuya Tomita; Mariana Kiomy Osako; Katsuto Tamai; Tadashi Tanabe; Yasufumi Kaneda; Hideki Yoshikawa; Ryuichi Morishita
Acceleration of wound healing by combined gene transfer of hepatocyte growth factor and prostacyclin synthase with Shima Jet.
Gene therapy 2006;13(15):1143-52.
2006: Naoyuki Sato; Masayasu Okochi; Yoshiaki Taniyama; Hitomi Kurinami; Munehisa Shimamura; Daisuke Takeuchi; Hizuki Hamada; Akio Fukumori; Kazuyuki Kiyosue; Takahisa Taguchi; Toshiyuki Tanaka; Masayuki Miyasaka; Masatoshi Takeda; Toshio Ogihara; Ryuichi Morishita
Development of new screening system for Alzheimer disease, in vitro Abeta sink assay, to identify the dissociation of soluble Abeta from fibrils.
Neurobiology of disease 2006;22(3):487-95.
2006: Nobutaka Koibuchi; Yoshiaki Taniyama; Kaori Nagao; Toshio Ogihara; Yasufumi Kaneda; Ryuichi Morishita
The effect of VEGF on blood vessels and blood cells during Xenopus development.
Biochemical and biophysical research communications 2006;344(1):339-45.
2005: Yoshiaki Taniyama; Ryuichi Morishita; Hiroshi Makino; Junya Azuma; Toshio Ogihara
[Gene therapy in congestive heart failure].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 12():594-7.
2005: Yoshiaki Taniyama; Ryuichi Morishita; Junya Azuma; Kazuma Iekushi
[Therapeutic angiogenesis for ischemic heart disease induced by gene transfer].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 12():588-93.
2005: Munehisa Shimamura; Naoyuki Sato; Yoshiaki Taniyama; Hitomi Kurinami; Hiroyuki Tanaka; Toshihiro Takami; Toshio Ogihara; Masaya Tohyama; Yasufumi Kaneda; Ryuichi Morishita
Gene transfer into adult rat spinal cord using naked plasmid DNA and ultrasound microbubbles.
The journal of gene medicine 2005;7(11):1468-74.
2005: Yoshiaki Taniyama; Ryuichi Morishita; Junya Azuma; Kazuma Iekushi; Toshio Ogihara
[Gene therapy for diabetic microangiopathy].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 6():153-8.
2005: Hiromi Koike; Naruya Tomita; Haruhito Azuma; Yoshiaki Taniyama; Keita Yamasaki; Yasuo Kunugiza; Katsuro Tachibana; Toshio Ogihara; Ryuichi Morishita
An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney.
The journal of gene medicine 2005;7(1):108-16.
2004: Kei Yamamoto; Naruya Tomita; Shin-ichi Yoshimura; Hironori Nakagami; Yoshiaki Taniyama; Keita Yamasaki; Toshio Ogihara; Ryuichi Morishita
Hypoxia-induced renal epithelial cell death through caspase-dependent pathway: role of Bcl-2, Bcl-xL and Bax in tubular injury.
International journal of molecular medicine 2004;14(4):633-40.
2004: Munehisa Shimamura; Naoyuki Sato; Yoshiaki Taniyama; S Yamamoto; M Endoh; Hitomi Kurinami; Motokuni Aoki; Toshio Ogihara; Yasufumi Kaneda; Ryuichi Morishita
Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound.
Gene therapy 2004;11(20):1532-9.
2004: Naruto Katsuragi; Ryuichi Morishita; Noriko Nakamura; Tayehito Ochiai; Yoshiaki Taniyama; Yasuhiro Hasegawa; Kayoko Kawashima; Yasufumi Kaneda; Toshio Ogihara; Keijiro Sugimura
Periostin as a novel factor responsible for ventricular dilation.
Circulation 2004;110(13):1806-13.
2004: Nobutaka Koibuchi; Yasufumi Kaneda; Yoshiaki Taniyama; Kunio Matsumoto; Toshikazu Nakamura; Toshio Ogihara; Ryuichi Morishita
Essential role of HGF (hepatocyte growth factor) in blood formation in Xenopus.
Blood 2004;103(9):3320-5.
2004: Naotaka Hashiya; Motokuni Aoki; Katsuro Tachibana; Yoshiaki Taniyama; Keita Yamasaki; Kazuya Hiraoka; Hirofumi Makino; Kaneda Yasufumi; Toshio Ogihara; Ryuichi Morishita
Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model.
Biochemical and biophysical research communications 2004;317(2):508-14.
2004: Yoshiaki Taniyama; Naruya Tomita; Seiji Endoh; Yasufumi Kaneda; Toshio Ogihara; Ryuichi Morishita
[Gene transfer with ultrasound and microbubbles (optison) as a potential treatment for cardiovascular diseases].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 2004;41(1):51-4.
2003: Naruya Tomita; Ryuichi Morishita; Yoshiaki Taniyama; Hiromi Koike; Motokuni Aoki; Hideo Shimizu; Kunio Matsumoto; Toshikazu Nakamura; Yasufumi Kaneda; Toshio Ogihara
Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1.
Circulation 2003;107(10):1411-7.
2002: Hironori Nakagami; Ryuichi Morishita; Kei Yamamoto; Yoshiaki Taniyama; Motokuni Aoki; Keita Yamasaki; Kunio Matsumoto; Toshikazu Nakamura; Yasufumi Kaneda; Toshio Ogihara
Hepatocyte growth factor prevents endothelial cell death through inhibition of bax translocation from cytosol to mitochondrial membrane.
Diabetes 2002;51(8):2604-11.
2002: Yoshiaki Taniyama; Ryuichi Morishita; Motokuni Aoki; Kazuya Hiraoka; Keita Yamasaki; Naotaka Hashiya; Kunio Matsumoto; Toshikazu Nakamura; Yasufumi Kaneda; Toshio Ogihara
Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy.
Hypertension 2002;40(1):47-53.
2002: Yoshiaki Taniyama; Katsuro Tachibana; Kazuya Hiraoka; Tsunetatsu Namba; Keita Yamasaki; Naotaka Hashiya; Motokuni Aoki; Toshio Ogihara; Kaneda Yasufumi; Ryuichi Morishita
Local delivery of plasmid DNA into rat carotid artery using ultrasound.
Circulation 2002;105(10):1233-9.
2002: Yoshiaki Taniyama; K Tachibana; Kazuya Hiraoka; Motokuni Aoki; Seiji Yamamoto; Kunihiro Matsumoto; Tadashi Nakamura; Toshio Ogihara; Yasufumi Kaneda; Ryuichi Morishita
Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle.
Gene therapy 2002;9(6):372-80.
2001: Yoshiaki Taniyama; Ryuichi Morishita; Kazuya Hiraoka; Motokuni Aoki; Hironori Nakagami; Keita Yamasaki; Kunihiro Matsumoto; Tadashi Nakamura; Yasufumi Kaneda; Toshio Ogihara
Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes.
Circulation 2001;104(19):2344-50.
2001: Naruya Tomita; Atsushi Moriguchi; Keita Yamasaki; Yoshiaki Taniyama; Noriko Kotani; Naotaka Hashiya; M Yoshida; M Yao; Jitsuo Higaki; Toshio Ogihara
A family with von Hippel-Lindau disease revealed by pheochromocytoma.
Hypertension research : official journal of the Japanese Society of Hypertension 2001;24(4):445-50.
2001: Hironori Nakagami; Ryuichi Morishita; Kazuhiro Yamamoto; S I Yoshimura; Yoshiaki Taniyama; Motokuni Aoki; H Matsubara; S Kim; Yasufumi Kaneda; Toshio Ogihara
Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells.
Diabetes 2001;50(6):1472-81.
2001: Atsunori Okamura; Hiromi Rakugi; Mitsuru Ohishi; Yoshihiro Yanagitani; M Shimizu; T Nishii; Yoshiaki Taniyama; T Asai; Shin Takiuchi; Kouichi Moriguchi; M Ohkuro; Norio Komai; K Yamada; Nozomu Inamoto; A Otsuka; Jitsuo Higaki; Toshio Ogihara
Additive effects of nicorandil on coronary blood flow during continuous administration of nitroglycerin.
Journal of the American College of Cardiology 2001;37(3):719-25.
2001: Yoshiaki Taniyama; Ryuichi Morishita; Motokuni Aoki; Hironori Nakagami; Kazuhiro Yamamoto; K Yamazaki; Kunihiro Matsumoto; Tadashi Nakamura; Yasufumi Kaneda; Toshio Ogihara
Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
Gene therapy 2001;8(3):181-9.
2001: Hironori Nakagami; Ryuichi Morishita; Kazuhiro Yamamoto; Yoshiaki Taniyama; Motokuni Aoki; Kunihiro Matsumoto; Tadashi Nakamura; Yasufumi Kaneda; M Horiuchi; Toshio Ogihara
Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells.
Hypertension 2001;37(2 Pt 2):581-6.
2000: Hironori Nakagami; Ryuichi Morishita; Kazuhiro Yamamoto; Yoshiaki Taniyama; Motokuni Aoki; S Kim; Kunihiro Matsumoto; Tadashi Nakamura; Jitsuo Higaki; Toshio Ogihara
Anti-apoptotic action of hepatocyte growth factor through mitogen-activated protein kinase on human aortic endothelial cells.
Journal of hypertension 2000;18(10):1411-20.
2000: Yoshiaki Taniyama; Ryuichi Morishita; Hironori Nakagami; Atsushi Moriguchi; H Sakonjo; Kunihiro Matsumoto; Tadashi Nakamura; Jitsuo Higaki; Toshio Ogihara
Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters.
Circulation 2000;102(2):246-52.
2000: H Matsushita; Ryuichi Morishita; T Nata; Motokuni Aoki; Hironori Nakagami; Yoshiaki Taniyama; K Yamamoto; Jitsuo Higaki; Kaneda Yasufumi; Toshio Ogihara
Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation.
Circulation research 2000;86(9):974-81.
2000: H Matsushita; Ryuichi Morishita; Motokuni Aoki; Naruya Tomita; Yoshiaki Taniyama; Hironori Nakagami; T Shimozato; Jitsuo Higaki; Yasufumi Kaneda; Toshio Ogihara
Transfection of antisense p53 tumor suppressor gene oligodeoxynucleotides into rat carotid artery results in abnormal growth of vascular smooth muscle cells.
Circulation 2000;101(12):1447-52.
2000: Motokuni Aoki; Ryuichi Morishita; Yoshiaki Taniyama; Iwao Kida; Atsushi Moriguchi; Kunihiro Matsumoto; Tadashi Nakamura; Yasufumi Kaneda; Jitsuo Higaki; Toshio Ogihara
Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets.
Gene therapy 2000;7(5):417-27.
2000: Motokuni Aoki; Ryuichi Morishita; Yoshiaki Taniyama; Yasufumi Kaneda; Toshio Ogihara
Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic diseases.
Journal of atherosclerosis and thrombosis 2000;7(2):71-6.
2000: Seiji Hayashi; Ryuichi Morishita; H Matsushita; Hironori Nakagami; Yoshiaki Taniyama; Tadashi Nakamura; Motokuni Aoki; Kazuhiro Yamamoto; Jitsuo Higaki; Toshio Ogihara
Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21.
Hypertension 2000;35(1 Pt 2):237-43.
1999: Atsunori Okamura; Mitsuru Ohishi; Hiromi Rakugi; Tomohiro Katsuya; Yoshihiro Yanagitani; Shin Takiuchi; Yoshiaki Taniyama; Kouichi Moriguchi; Hiroshi Ito; Yorihiko Higashino; Kenshi Fujii; Jitsuo Higaki; Toshio Ogihara
Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty.
Angiology 1999;50(10):811-22.
1999: Ryuichi Morishita; Shun Nakamura; Seiji Hayashi; Yoshiaki Taniyama; Atsushi Moriguchi; T Nagano; Mutsuo Taiji; H Noguchi; S Takeshita; Kunihiro Matsumoto; Tadashi Nakamura; Jitsuo Higaki; Toshio Ogihara
Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy.
Hypertension 1999;33(6):1379-84.
1999: Hiroshi Ito; Yoshiaki Taniyama; Katsuomi Iwakura; Nagahiro Nishikawa; Tohru Masuyama; Tsunehiko Kuzuya; Masatsugu Hori; Yorihiko Higashino; Kenshi Fujii; Tetsuo Minamino
Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction.
Journal of the American College of Cardiology 1999;33(3):654-60.
1998: Shin Takiuchi; Hiroshi Ito; Katsuomi Iwakura; Yoshiaki Taniyama; Nagahiro Nishikawa; Tohru Masuyama; Masatsugu Hori; Yorihiko Higashino; Kenshi Fujii; Tetsuo Minamino
Ultrasonic tissue characterization predicts myocardial viability in early stage of reperfused acute myocardial infarction.
Circulation 1998;97(4):356-62.
1997: Yoshiaki Taniyama; Hiroshi Ito; Katsuomi Iwakura; Tohru Masuyama; Masatsugu Hori; Shin Takiuchi; Nagahiro Nishikawa; Yorihiko Higashino; Kenshi Fujii; Tetsuo Minamino
Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction.
Journal of the American College of Cardiology 1997;30(5):1193-9.
1996: Katsuomi Iwakura; Hiroshi Ito; Shin Takiuchi; Yoshiaki Taniyama; Y Nakatsuchi; S Negoro; Yorihiko Higashino; Atsunori Okamura; Tohru Masuyama; Masatsugu Hori; Kenshi Fujii; Tetsuo Minamino
Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction.
Circulation 1996;94(6):1269-75.
1996: Hiroshi Ito; Atsunori Okamura; Katsuomi Iwakura; Tohru Masuyama; Masatsugu Hori; Shin Takiuchi; S Negoro; Y Nakatsuchi; Yoshiaki Taniyama; Yorihiko Higashino; Kenshi Fujii; Tetsuo Minamino
Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction.
Circulation 1996;93(11):1993-9.
1996: Kenshi Fujii; Atsunori Okamura; Shin Takiuchi; Yoshiaki Taniyama; M Ohishi; T Ogihara
[Clinical characteristics and therapeutic strategy for acute myocardial infarction in the elderly].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1996;33(4):249-54.